humanitarian
Human medicines European public assessment report (EPAR): Livtencity, maribavir, Date of authorisation: 09/11/2022, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Phesgo, pertuzumab,trastuzumab, Date of authorisation: 21/12/2020, Revision: 8, Status: Authorised
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewHuman medicines European public assessment report (EPAR): Livtencity, maribavir, Date of authorisation: 09/11/2022, Revision: 9, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Livtencity, maribavir, Date of authorisation: 09/11/2022, Revision: 9, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Trisenox, arsenic trioxide, Date of authorisation: 05/03/2002, Revision: 34, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Trisenox, arsenic trioxide, Date of authorisation: 05/03/2002, Revision: 34, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Fampyra, fampridine, Date of authorisation: 20/07/2011, Revision: 20, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Fampyra, fampridine, Date of authorisation: 20/07/2011, Revision: 20, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Palbociclib Viatris, palbociclib, Date of authorisation: 19/06/2026, Revision: 1, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Palbociclib Viatris, palbociclib, Date of authorisation: 19/06/2026, Revision: 1, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Tenkasi (previously Orbactiv), oritavancin, Date of authorisation: 19/03/2015, Revision: 18, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Tenkasi (previously Orbactiv), oritavancin, Date of authorisation: 19/03/2015, Revision: 18, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Pemazyre, pemigatinib, Date of authorisation: 26/03/2021, Revision: 8, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Pemazyre, pemigatinib, Date of authorisation: 26/03/2021, Revision: 8, Status: Authorised3 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources